Impact of 18F-fluciclovine PET/CT findings on failure-free survival in biochemical recurrence of prostate cancer following salvage radiation therapy

Abiodun-Ojo, Olayinka A.; Adediran, Omotayo A.; Dhere, Vishal R.; Fielder, Bridget; Goodman, Mark; Goyal, Subir; Halkar, Raghuveer K.; Hershatter, Bruce; Jani, Ashesh B.; Joshi, Shreyas S.; Kucuk, Omer; Lawal, Ismaheel Opeyemi; Marcus, Charles; Master, Viraj A.; Patel, Pretesh R.; Schuster, David M.; Shelton, Joseph W.

Impact of 18F-fluciclovine PET/CT findings on failure-free survival in biochemical recurrence of prostate cancer following salvage radiation therapy

Authors: Olayinka A. Abiodun-Ojo
Omotayo A. Adediran
Vishal R. Dhere
Bridget Fielder
Mark Goodman
Subir Goyal
Raghuveer K. Halkar
Bruce Hershatter
Ashesh B. Jani
Shreyas S. Joshi
Omer Kucuk
Ismaheel Opeyemi Lawal
Charles Marcus
Viraj A. Master
Pretesh R. Patel
David M. Schuster
Joseph W. Shelton
Publication date: 1 April 2023
Publisher: Lippincott Williams and Wilkins
Doi

Abstract

Please read abstract in the article.The EMPIRE-1 trial received funding from the National Institutes of Health/National Cancer Institute (R01 CA16918), Blue Earth Diagnostics, Ltd., and the Winship Cancer Institute of Emory University.http://journals.lww.com/nuclearmed/pages/default.aspx2023-12-14Nuclear Medicin

Similar works

Full text

Available Versions

UPSpace at the University of Pretoria

oai:repository.up.ac.za:2263/9...

Last time updated on 11/11/2023